Abbott’s PLEX-ID Molecular system and tests for broad microbial identification obtain CE Marking
30 March 2012 | By Abbott
New PLEX-ID system and three clinical tests introduced in the European Union...
List view / Grid view
Abbott Laboratories is an American worldwide healthcare company. With headquarters in Lake Bluff, Illinois, it has 94,000 employees and operates in more than 150 countries.
The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; it eventually grew to also sell research-based drugs, medical devices, diagnostics, and nutritional products. It split off the research-based pharmaceuticals into Abbvie in 2013. In 2015, revenues were $20.4 billion.
Abbott has a broad range of branded generic pharmaceuticals, medical devices, diagnostics, and nutrition products. The company’s in-vitro diagnostics business performs immunoassays and blood screening. Its medical tests and diagnostic instrument systems are used worldwide by hospitals, laboratories, blood banks, and physician offices to diagnose and monitor diseases such as HIV, hepatitis, cancer, heart failure and metabolic disorders, as well as assess other indicators of health. In 1985, the company developed the first HIV blood-screening test.
30 March 2012 | By Abbott
New PLEX-ID system and three clinical tests introduced in the European Union...
21 March 2012 | By Abbott
AbbVie the new, independent research-based pharmaceutical company...
20 March 2012 | By Abbott
Abbott announced the company's schedule of key presentations...
Abbott today announced the initiation of two Phase 3 clinical trials designed to evaluate the safety and efficacy of an investigational use of HUMIRA® (adalimumab) in adult patients with moderate to severe hidradenitis suppurativa (HS).
8 March 2012 | By Abbott
U.S. FDA clearance for the FreeStyle InsuLinx Blood Glucose Monitoring System...
7 March 2012 | By Abbott
The U.S. FDA approved the Absolute Pro® Vascular Self-Expanding Stent System...
6 March 2012 | By Abbott
Abbott will collaborate with Merck to evaluate the use of a FISH-based companion diagnostic test...
5 March 2012 | By Abbott
Abbott announced it will collaborate with Genetics Laboratory, Inc. (GenLab)...
2 March 2012 | By Abbott
STARLIMS Technologies announced the acquisition of longtime distribution partners...
1 March 2012 | By Abbott
Plant to employ 240 to meet fast-growing demand for adult nutrition products...
29 February 2012 | By Abbott
Abbott and Galapagos have entered into a global collaboration...
23 February 2012 | By Abbott
UNT Health Science Center Evaluating Abbott’s PLEX-ID System & Mitochondrial DNA Assay...
17 February 2012 | By Abbott
Positive opinion based on supporting data from two Phase III clinical studies...
13 February 2012 | By Abbott
Accurate and precise lab-to-lab monitoring is essential for long-term transplant success...
8 February 2012 | By Abbott
Abbott introduces Similac SimplySmart, an innovative BPA-free baby bottle designed to improve the bottle feeding experience...